
Nizal S. Chandrakumar
Examiner (ID: 111, Phone: (571)272-6202 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625 |
| Total Applications | 2819 |
| Issued Applications | 1922 |
| Pending Applications | 209 |
| Abandoned Applications | 730 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14611469
[patent_doc_number] => 10358420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-23
[patent_title] => Process for preparing an N-methyl-substituted triacetonamine compound
[patent_app_type] => utility
[patent_app_number] => 15/643081
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15259
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 261
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15643081
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/643081 | Process for preparing an N-methyl-substituted triacetonamine compound | Jul 5, 2017 | Issued |
Array
(
[id] => 12000171
[patent_doc_number] => 20170304326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'PHARMACEUTICAL COMPOSITION INCLUDING MIGRATORY FACTOR FOR GUIDING PLURIPOTENT STEM CELLS TO DAMAGE'
[patent_app_type] => utility
[patent_app_number] => 15/642534
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7742
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15642534
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/642534 | Pharmaceutical composition including migratory factor for guiding pluripotent stem cells to damage | Jul 5, 2017 | Issued |
Array
(
[id] => 12584865
[patent_doc_number] => 20180086784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => Phosphonate analogs of HIV inhibitor compounds
[patent_app_type] => utility
[patent_app_number] => 15/643168
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36644
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15643168
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/643168 | Phosphonate analogs of HIV inhibitor compounds | Jul 5, 2017 | Abandoned |
Array
(
[id] => 12126239
[patent_doc_number] => 20180009825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'METHODS OF MAKING ERIBULIN MESYLATE'
[patent_app_type] => utility
[patent_app_number] => 15/641831
[patent_app_country] => US
[patent_app_date] => 2017-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6059
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15641831
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/641831 | METHODS OF MAKING ERIBULIN MESYLATE | Jul 4, 2017 | Abandoned |
Array
(
[id] => 14624479
[patent_doc_number] => 20190225607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => Deuterated Venetoclax
[patent_app_type] => utility
[patent_app_number] => 16/315550
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315550
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315550 | Deuterated Venetoclax | Jun 29, 2017 | Abandoned |
Array
(
[id] => 13013849
[patent_doc_number] => 10030032
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Methods useful in the synthesis of halichondrin B analogs
[patent_app_type] => utility
[patent_app_number] => 15/638493
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6192
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15638493
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/638493 | Methods useful in the synthesis of halichondrin B analogs | Jun 29, 2017 | Issued |
Array
(
[id] => 13748661
[patent_doc_number] => 10167260
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-01
[patent_title] => 2-aminopyridine-based selective neuronal nitric oxide synthase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/639824
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4793
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15639824
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/639824 | 2-aminopyridine-based selective neuronal nitric oxide synthase inhibitors | Jun 29, 2017 | Issued |
Array
(
[id] => 13151611
[patent_doc_number] => 10092508
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Polymer implants for treatment of metabolic disorders
[patent_app_type] => utility
[patent_app_number] => 15/634093
[patent_app_country] => US
[patent_app_date] => 2017-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 28
[patent_no_of_words] => 6612
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15634093
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/634093 | Polymer implants for treatment of metabolic disorders | Jun 26, 2017 | Issued |
Array
(
[id] => 12750802
[patent_doc_number] => 20180142101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => METHOD OF SEPARATING OIL-SOLUBLE PIGMENT AND WATER-SOLUBLE PIGMENT FROM NATURAL MATERIAL USING AEROGELS AND AN APPARATUS THEREFOR
[patent_app_type] => utility
[patent_app_number] => 15/627600
[patent_app_country] => US
[patent_app_date] => 2017-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15627600
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/627600 | Method of separating oil-soluble pigment and water-soluble pigment from natural material using aerogels and an apparatus therefor | Jun 19, 2017 | Issued |
Array
(
[id] => 13853847
[patent_doc_number] => 10188629
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Prodrug of green tea epigallocatechin-3-gallate (pro-EGCG) for use in the treatment of endometriosis
[patent_app_type] => utility
[patent_app_number] => 15/628001
[patent_app_country] => US
[patent_app_date] => 2017-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 5868
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15628001
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/628001 | Prodrug of green tea epigallocatechin-3-gallate (pro-EGCG) for use in the treatment of endometriosis | Jun 19, 2017 | Issued |
Array
(
[id] => 14534455
[patent_doc_number] => 20190202849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => METHOD FOR THE PREPARATION OF SUBSTITUTED THIOLACTONES, NEW SUBSTITUTED THIOLACTONES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/311551
[patent_app_country] => US
[patent_app_date] => 2017-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311551
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311551 | METHOD FOR THE PREPARATION OF SUBSTITUTED THIOLACTONES, NEW SUBSTITUTED THIOLACTONES AND USES THEREOF | Jun 19, 2017 | Abandoned |
Array
(
[id] => 12029430
[patent_doc_number] => 20170319529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'Compounds and Methods for Modulating Vascular Injury'
[patent_app_type] => utility
[patent_app_number] => 15/627194
[patent_app_country] => US
[patent_app_date] => 2017-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 23041
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15627194
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/627194 | Compounds and Methods for Modulating Vascular Injury | Jun 18, 2017 | Abandoned |
Array
(
[id] => 13687347
[patent_doc_number] => 20170354628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => METHOD OF TREATING OBESITY WITH CHLOROGENIC ACID
[patent_app_type] => utility
[patent_app_number] => 15/626125
[patent_app_country] => US
[patent_app_date] => 2017-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15626125
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/626125 | Method of treating obesity with chlorogenic acid | Jun 17, 2017 | Issued |
Array
(
[id] => 13887695
[patent_doc_number] => 10196388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-05
[patent_title] => Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
[patent_app_type] => utility
[patent_app_number] => 15/624227
[patent_app_country] => US
[patent_app_date] => 2017-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11823
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15624227
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/624227 | Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists | Jun 14, 2017 | Issued |
Array
(
[id] => 15038401
[patent_doc_number] => 20190330205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => PYRROLOQUINOLINE QUINONE MONOSODIUM AND METHOD FOR PRODUCING THE SAME, AND COMPOSITION COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/309179
[patent_app_country] => US
[patent_app_date] => 2017-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309179
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/309179 | Pyrroloquinoline quinone monosodium and method for producing the same, and composition comprising the same | Jun 14, 2017 | Issued |
Array
(
[id] => 16564207
[patent_doc_number] => 10889565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => 4-hydroxy-3-sulfonylpyridin-2(1H)-ones as APJ receptor agonists
[patent_app_type] => utility
[patent_app_number] => 16/309168
[patent_app_country] => US
[patent_app_date] => 2017-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21075
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309168
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/309168 | 4-hydroxy-3-sulfonylpyridin-2(1H)-ones as APJ receptor agonists | Jun 13, 2017 | Issued |
Array
(
[id] => 14836013
[patent_doc_number] => 20190276407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => NOVEL PYRIDONECARBOXYLIC ACID DERIVATIVE OR SALT THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/308292
[patent_app_country] => US
[patent_app_date] => 2017-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308292
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308292 | Pyridonecarboxylic acid derivative or salt thereof | Jun 13, 2017 | Issued |
Array
(
[id] => 11969817
[patent_doc_number] => 20170273972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 15/621013
[patent_app_country] => US
[patent_app_date] => 2017-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 80878
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15621013
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/621013 | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators | Jun 12, 2017 | Issued |
Array
(
[id] => 17938530
[patent_doc_number] => 11472972
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => 3-ketocoumarins, a process for their preparation and their use as photoinitiators in photopolymerization reactions
[patent_app_type] => utility
[patent_app_number] => 16/310123
[patent_app_country] => US
[patent_app_date] => 2017-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5878
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16310123
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/310123 | 3-ketocoumarins, a process for their preparation and their use as photoinitiators in photopolymerization reactions | Jun 11, 2017 | Issued |
Array
(
[id] => 12786154
[patent_doc_number] => 20180153887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
[patent_app_type] => utility
[patent_app_number] => 15/618464
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19903
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15618464
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/618464 | POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE | Jun 8, 2017 | Abandoned |